To review published algorithms for guiding the use of methylphenidate (MPH) in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents.
Methods:
A consensus roundtable of 12 experts was convened to review the evidence for the safety and efficacy of MPH in the treatment of ADHD, as well as the published algorithms and practice guidelines for using MPH. The experts reviewed the algorithms for practicality and acceptability by clinicians.
Results:
Algorithms that included MPH commonly selected it as the initial medication to be employed in the treatment of children with ADHD. Factors involved included its high efficacy, good safety record, and the ubiquitous nature of its appearance in the ADHD treatment literature.
Conclusions:
MPH should be considered as the first medication to be used in a treatment algorithm for children and adolescents with ADHD.
Get full access to this article
View all access options for this article.
References
1.
2002 Drug Topics Red Book (2002) Montvale, NJ: Thomson Medical Economics.
2.
American Academy of Child and Adolescent Psychiatry (1991). Practice parameters for the assessment and treatment of children, adolescents, and adults with Attention-Deficit/Hyperactivity Disorder,Journal of the American Academy of Child and Adolescent Psychiatry,30(3), i–iii.
3.
American Academy of Child and Adolescent Psychiatry (1997). Practice Parameters for the assessment and treatment of Attention-Deficit/Hyperactivity Disorder. M. Dulcan (Ed.), Journal of the American Academy of Child and Adolescent Psychiatry, 36(10), 85S–121S.
4.
American Academy of Child and Adolescent Psychiatry (2002). Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Edited by L. L. Greenhill, S. Pliszka, & M. Dulcan, Journal of the American Academy of Child Adolescent Psychiatry, 41(2), 26S–49S.
5.
American Academy of Pediatrics (2000). Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder.Pediatrics, 105(5), 1158–1170.
6.
American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. (2001[)] Clinical practice guideline: treatment of the school-aged child with Attention-Deficit/Hyperactivity Disorder.Pediatrics,108(4), 1033–1044.
7.
American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th Editition (DSM-IV).Washington DC: American Psychiatric Association.
8.
CohenP., CohenJ., KasenS., VelezC. N., HartmarkC., JohnsonJ. (1993). An epidemiological study of disorders in late childhood and adolescence: Age-and gender-specific prevalence.Journal of Child Psychology and Psychiatry, 34, 851–867.
9.
Columbia University Treatment Guidelines (2002). ADHD. (Version 2) Columbia University, Department of Child and Adolescent Psychiatry, New York, NY.
ConnersC. K., MarchJ. S., FrancesA., WellsK. C., & RossR. (Eds.) (2001). Expert Consensus Guideline Series. Treatment of attention-deficit/hyperactivity disorder [Special Issue].Journal of Attention Disorders, 4(Suppl 1).
12.
GaubM., & CarlsonC.L.. (1997). Gender differences in ADHD: A meta-analysis and critical review.Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1036–1045.
13.
GilbertD. A., AltshulerK.Z., RagoW. V., ShonS. P., CrismonM. L., TopracM. G. (1998). Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.The Journal of Clinical Psychiatry, 59(7), 345–351.
14.
GoldmanL. S., GenelM., BezmanR. J., & SlanetzP. J.. (1998). Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.Journal of the American Medical Association, 279(14), 1100–1107.
15.
GoldnerE. M., & BilskerD.. (1995[)] Evidence-based psychiatry.Canadian Journal of Psychiatry,40(2), 97–101.
16.
GrimshawJ. M., & RussellI. T.. (1993). Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.Lancet, 342(8883), 1317–1322.
17.
GuyW.. (1976). ECDEU assessment manual for psychopharmacology—Revised.Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp. 218-222.
18.
InouyeJ., KristopatisR., StoneE., PelterM., SandhuM., & WeingartenS.. (1998). Physicians’ changing attitudes toward guidelines.Journal of General Internal Medicine, 13(5), 324–326.
MannuzzaS., KleinR. G., BesslerA., MalloyP., & LaPadulaM.. (1993). Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.Archives of General Psychiatry, 50(17), 565–576.
21.
MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for Attention-Deficit/Hyperactivity Disorder. Multimodal Treatment Study of Children with ADHD.Archives of General Psychiatry, 56(12), 1073–1086.
22.
National Institutes of Health Consensus Development (2000). Conference Statement: Diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)Journal of the American Academy of Child and Adolescent Psychiatry, 39(2), 182–193.
23.
OffordD. R., BoyleM. H., SzatmariP., Rae-GrantN. I., LinksP. S., CadmanD. T. (1987). Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization.Archives of General Psychiatry, 44(9), 832–836.
24.
PelhamW.. (1994). Pharmacotherapy of Children with Attention Deficit Hyperactivity Disorder.School Psychology Review, 22, 199–227.
25.
PliszkaS. R., GreenhillL. L., CrismonM. L., SedilloA., CarlsonC., ConnersC. K. (2000a). The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder: I. Attention-deficit/hyperactivity disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 39,(7), 908–919.
26.
PliszkaS. R., GreenhillL. L., CrismonM. L., SedilloA., CarlsonC., ConnersC. K. (2000b). The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder: II: Tactics. Attention-deficit/hyperactivity disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 39(7), 920–927.
27.
RossD. M., & RossS.A.. (1992). Hyperactivity: Current issues. Research and Theory.New York, NY: Wiley.
28.
SachsG. S., & GaughanS.. (1999). Clinical practice guidelines: Praise and problems.The Journal of Clinical Psychiatry, 60(1), 7–8.
29.
SwansonJ.. (1992). School-based assessments and interventions for ADD students.Irvine, CA: KC publishing.
30.
SwansonJ., KraemerH., HinshawS., ArnoldL., ConnersC. K., ElliottG. (2001). Clinical relevance of the primary findings of the MTA: Success rates based on the severity of ADHD and ODD symptoms at the end of treatment.Journal of the American Academy of Child and Adolescent Psychiatry, 20(2), 168–179.
31.
SwansonJ., WigalS., GreenhillL., BrowneR., WaslickB., LernerM. (1998). Objective and subjective measures of pharmacodynamic effects of Adderall® in the treatment of children with ADHD in a controlled laboratory classroom setting.Psychopharmacology Bulletin, 34(1), 55–60.
32.
WeingartenS.. (1997). Practice guidelines and prediction rules should be subject to careful clinical testing.Journal of the American Medical Association, 277(24), 1977–1978.
33.
WeissG., HechtmanL., MilroyT., & PerlmanT.. (1985). Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children.Journal of the American Academy of Child and Adolescent Psychiatry, 24(2), 211–220.
34.
WeissG., & HechtmanL. T.. (1993). Hyperactive children grown up. 2nd ed.New York, NY: Guildford.
35.
World Health Organization (1993). The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for research.Geneva: World Health Organisation.
36.
WoolfS. H.. (1992). Practice guidelines, a new reality in medicine. II. Methods of developing guidelines.Archives of Internal Medicine, 152(5), 946–952.
37.
WoolfS. H.. (1993). Practice guidelines: A new reality in medicine. III. Impact on patient care.Archives of Internal Medicine, 153(23), 2646–2655.
